Document ID: chunk:federal_register_of_legislation:F2024L01401:schedule:1:p2
Version: federal_register_of_legislation:F2024L01401
Segment Type: schedule
Provision Reference: sch 1 (pt 2/7)
Character Range: 7045–17315

research is fit for purpose, high quality, good value, trusted by the community and efficiently delivers the best possible research outcomes for improving the health and wellbeing of people in Australia.                                                                                                                                                                                                                                                                                                                                                                                                                               Support meaningful and respectful consumer and community involvement and engagement in the prioritisation, design, conduct, translation, dissemination and evaluation of MRFF-funded research, and promote consumer and community leadership and partnership with researchers across all types of research.
Research that is driven by meaningful consumer and community involvement and partnerships, to incorporate their diverse priorities, needs, values and experiences to deliver outcomes that are accessible, useful and used by consumers, carers, health care professionals and other end-users.

Research Infrastructure and Capability                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Support access to expertise and infrastructure that facilitates innovation and the development of research discoveries for practical impact.
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Access to advanced biomedical and digital research and translation assets as well as relevant expertise, collaborations, and networks will ensure that discoveries are effectively and rapidly converted to new preventive interventions, diagnostics, therapeutic products, and medical devices, based on quality data.
Address gaps in the generation of knowledge, in early biomedical and medical technology product development and translational research by supporting access to expertise, capability, and infrastructure, in partnership with industry to drive new research discoveries and accelerate innovation. This includes research facilities, equipment, systems, services, networks, digital infrastructure, integrated data, and biobanks.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Emphasis should be placed on building capacity and capability, including through increased collaboration and partnerships across the research sector and with industry. This includes better integration with other government infrastructure programs such as the National Collaborative Research Infrastructure Strategy (NCRIS) program and the National One Stop Shop for clinical trials.

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Support for translation of research into improved health care, new health care technologies and treatments including therapeutics, drugs, devices, and models of care.
Translation and Commercialisation
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Australia is recognised as a world leader in biomedical research outputs. Capitalising on these investments is critical to ensure that research discoveries have a pathway to translation and commercialisation to better realise health and economic benefits.                                                                                                                                                                                                                                                                                                                                                                                                                                                      Support the ecosystem for small and medium enterprises (SMEs) or not-for-profits to translate early-stage health and medical research with commercial potential into products or services.
Provide a focus on research translation, implementation and commercialisation by accelerating and advancing innovation to improve health outcomes and impact, and by supporting the development of biomedical research industries in Australia. Leverage opportunities from novel or emerging tools and technologies that can transform health and medical research, health interventions and care. This includes building the evidence base for improved adoption into health care and policy, as well as increasing collaborations between the research sector, industry, health services, governments, and community.
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Facilitate progress along the translation and commercialisation pipeline and de-risk projects